CASI Pharmaceuticals To Host Business Update Call March 12, 2021
News provided by
Share this article
Share this article
ROCKVILLE, Md. and BEIJING, March 11, 2021 /PRNewswire/ CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, today announced the Company will host a conference call at 8:00 a.m. ET on Friday, March 12, 2020.
On the call, CASI s Chairman & CEO will provide an update on recent business developments and review upcoming milestones. The conference call can be accessed by dialing (877) 405-1224 (U.S.), (86) 400-120-2840 (China), (800) 965-561 (Hong Kong) to listen to the live presentation. The live webcast can be accessed at the following link: https://78449.themediaframe.com/dataconf/productusers/casi/mediaframe/44098/indexl.html
Penny Stocks To Watch Before 2021 Up Big In Q4
Will These Penny Stocks Reach New Highs Before Next Year?
Looking for penny stocks to buy can be easier said than done. One of the main reasons is that emotions can easily impact when and how you buy or sell. Simply put, it isn’t uncommon to see these cheap stocks race higher, quickly. But just as quickly as they climb, they can also fall. Having a proper strategy in place and nerves of steel helps avoid emotional trading.
Set proper profit targets and stick to your plan. The way traders lose with penny stocks is holding on too long and “hoping” the move continues. Most new traders will take all of the money they have in an account and throw it into a stock at one price in an “all or nothing strategy”. This isn’t the best tactic to use in my opinion.
CASI Pharmaceuticals Announces Appointment Of Chief Financial Officer
News provided by
Share this article
Share this article
ROCKVILLE, Md., and BEIJING, Dec. 16, 2020 /PRNewswire/ CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, today announces the appointment of Weihao Xu to the position of Chief Financial Officer. Mr. Xu will report to Dr. Wei-Wu He, Chairman and CEO of CASI.
Most recently, in January 2020, Mr. Xu founded and served as Chief Investment Officer for Permanence Capital LLC, a healthcare-dedicated investment firm. From February 2018 until March 2019, he served as Chief Financial Officer for 111, Inc. a Shanghai-based digital healthcare company, where he led the initial public offering of the company on NASDAQ, and oversaw the company s financial operations, corporate strategy and investor relations. Prior to that, Mr. Xu served as a portfoli